Tenovi launches Gen 3 blood pressure monitor for remote hypertension care

Tenovi introduced its Gen 3 Blood Pressure Monitor on July 20, 2026, adding an FDA-cleared remote hypertension device to its connected monitoring platform. The launch aims to help health systems, payers, and care organizations catch out-of-range readings sooner and manage more patients through a single cellular-connected RPM infrastructure.

Why it matters: - Hypertension affects nearly 48% of U.S. adults and is a leading driver of cardiovascular hospitalizations. - Blood pressure control is one of the highest-weighted clinical measures in Medicare Advantage Star Ratings. - CMS guidance credits remote, device-transmitted blood pressure readings toward that measure, the same as an in-clinic reading. - Remote blood pressure monitoring can surface elevated readings between visits, when intervention may help avoid a hospitalization.

What happened: - Tenovi launched the Tenovi Gen 3 Blood Pressure Monitor on July 20, 2026. - The device is FDA-cleared for remote hypertension management. - Tenovi positioned the launch as part of a broader remote monitoring suite for health systems, payers and care organizations.

The details: - The Gen 3 BPM includes a standard single-measurement button. - The device also offers a triple-measurement option that takes three back-to-back readings and shows the average. - A built-in voice assist feature reads results aloud for patients with visual impairments or those who prefer audio. - An irregular heartbeat detection feature flags notable rhythm variations during a measurement. - New scroll buttons let patients review past readings directly on the device's LCD screen. - The Tenovi Cellular Gateway automatically and securely sends patient vitals to clinical care teams without manual syncing or a smartphone app. - The Gateway uses a multi-carrier SIM and an antenna tuned for U.S. carrier networks. - The Gateway includes cell phone fallback to help transmit data in areas with inconsistent cellular coverage. - A visual light system reminds patients to take a morning measurement and turns green after transmission to the care team. - Tenovi now offers more than 60 connected health device solutions that transmit data through the Cellular Gateway and a single API. - Tenovi's platform lets healthcare teams support an entire program's device mix with one integration. - Health systems and payers can use one infrastructure vendor across a member population's monitoring needs instead of juggling multiple device suppliers. - Tenovi is a data aggregation and automation healthcare IoT platform that connects remote medical device data with clinical care teams. - Tenovi says its API-driven fulfillment and automation services are built to support remote patient monitoring and remote therapeutic monitoring deployments. - Tenovi ranks No. 55 nationwide on the 2025 Inc. 5000 list, No. 11 in healthcare, No. 1 in New Hampshire and No. 2 in Boston.

Between the lines: - The launch extends Tenovi's strategy of selling a connected device portfolio around a single cellular gateway and API. - The message to buyers is operational as much as clinical: fewer integrations, fewer vendors and less manual work. - The company is leaning on reimbursement and quality-measure alignment to show why remote blood pressure capture matters now.

What's next: - Tenovi is likely to use the Gen 3 BPM to deepen adoption across existing RPM and RTM programs. - Health systems and payers can expand connected blood pressure monitoring without adding a separate device workflow. - The broader platform approach suggests more device additions may follow as Tenovi builds out its catalog.